2004
DOI: 10.1097/00004850-200405000-00003
|View full text |Cite
|
Sign up to set email alerts
|

Depression in the Italian community: epidemiology and socio-economic implications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(8 citation statements)
references
References 23 publications
0
8
0
Order By: Relevance
“…Although the prevalence of late-life depression reported by several studies varies from lower than 1% to more than 35% [ 1 - 3 ], depression is one of the major health problems in the elderly, and the burden of inadequately treated late-life depression is substantial [ 2 , 4 ]. The World Health Organization predicted that depression would be the second greatest cause of disease burden by the year 2020 [ 5 , 6 ], probably due to the remarkably accelerating rate of population aging [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…Although the prevalence of late-life depression reported by several studies varies from lower than 1% to more than 35% [ 1 - 3 ], depression is one of the major health problems in the elderly, and the burden of inadequately treated late-life depression is substantial [ 2 , 4 ]. The World Health Organization predicted that depression would be the second greatest cause of disease burden by the year 2020 [ 5 , 6 ], probably due to the remarkably accelerating rate of population aging [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…A survey of 5,566 subjects conducted by phone, utilizing the Mini-International Neuropsychiatric Interview as a diagnostic instrument, noted that depressed subjects undergo nonpsychiatric diagnostic procedures 3 times more frequently than nondepressed subjects [23] .…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, 34,2% of patients with MDD receiving medical advice had not received any prescription, while 36,8 % had started medical treatments more than once. Furthermore, the number of consultations, of pharmacological treatments and diagnostics were three times bigger in patients with MDD compared to individuals without depressive symptoms, while the number of absences from work lasting more than one week occurring in the last 6 months was four times bigger (Battaglia, Dubini, Mannheimer & Pancheri, 2004). In existing literature, this important diagnostic and therapeutic unmet need has been attributed not only to the poor awareness, social stigma and the mistrust in pharmacological treatments, but also to the great variability in doctors' ability to correctly recognize and interpret the disease symptoms (Lasalvia et al, 2013).…”
Section: Introductionmentioning
confidence: 91%